Canalyst

Canalyst is a financial data and search platform that provides structured fundamental models and data for public equities, with a specialized vertical dedicated to the life sciences and biotechnology sectors. The company offers investment professionals pre-built, downloadable Excel models for over 800 biotech companies, incorporating detailed clinical trial trackers, regulatory milestone projections, and asset-level net present value (NPV) analysis. By automating the extraction of data from SEC filings and clinical press releases, Canalyst enables analysts to perform rapid fundamental benchmarking and valuation. In August 2022, Canalyst was acquired by Tegus, an investment research platform, to integrate its high-fidelity financial data into a broader suite of research tools. The platform remains a critical resource for buy-side and sell-side analysts focusing on the complex financial modeling required for drug development companies.